✦ LIBER ✦

Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome

✍ Scribed by Fernando Callera; Carlos O. Lopes; Evandro S. Rosa; Carla C. Mulin

Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 67 KB
Volume: 32
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.02.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes after induction chemotherapy in

Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome

✍ Celeste Bello; Daohai Yu; Rami S. Komrokji; Weiwei Zhu; Gene A. Wetzstein; Alan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Insufficient outcomes with imatinib mesy

Insufficient outcomes with imatinib mesylate: Case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome

✍ Atsushi Isoda; Hirotaka Nakahashi; Takumi Hoshino; Takeki Mitsui; Yasushi Yoshid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 2 views

The clinical significance of soluble CD8

The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome

✍ Barry D. Hock; Judith L. McKenzie; William Nigel Patton; Lisa F. Haring; Ying Ya 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

## Abstract ## BACKGROUND Levels of the soluble form of CD86 (sCD86) are elevated in a proportion of patients with leukemia. Although it is a potential modulator of antitumor responses, the significance of sCD86 in patients with hematologic malignancies is unknown. ## METHODS The authors evaluat

Therapy for elderly patients with acute

Therapy for elderly patients with acute myeloid leukemia : A problem in search of solutions

✍ Hagop M. Kantarjian 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

Use of white blood cell growth factors a

Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma

✍ Stephen K. Gruschkus; David Lairson; J. Kay Dunn; Jan Risser; Xianglin L. Du 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Prognostic value of immunophenotyping in

Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia : A single-institution experience

✍ Claudiu Plesa; Youcef Chelghoum; Adriana Plesa; Mohamed Elhamri; Isabelle Tigaud 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract ## BACKGROUND. The poor prognosis for elderly patients with acute myeloid leukemia (AML) raises questions regarding the benefit of treating them with intensive chemotherapy. The impact of initial characteristics on prognosis has been addressed previously in elderly patients; however, v